ADMA Biologics Inc (NASDAQ:ADMA)

Delayed Data
As of 9:31am ET
 +0.04 / +0.47%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for ADMA Biologics Inc have a median target of 19.00, with a high estimate of 20.00 and a low estimate of 17.50. The median estimate represents a +124.06% increase from the last price of 8.48.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in ADMA Biologics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -0.66%
Growthannually -11.49%


Growthquarterly 0.57%
Growthannually 7.46%
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account